Click here for Our Skincare Division

OC 949-428-4500
LA 310-460-2444

Exciting Stem Cell (FDA:HCT/P) News

Placental / Umbilical Tissues / Biological Allografts /Human Cellular Tissue Products (HCT/P)
We are excited to inform you that under the guidance of the Food and Drug Administration  and with the cellular, biological and tissue laboratory expertise of Vitti Labs, our Regenerative Medicine program, which utilizes biological allografts (i.e., stem cells), including cells derived from umbilical and placental tissues, is currently in the process of being restructured.
A syringe sits between 2 vials of Mesenchymal Stem Cells.

Indeed, AMA and Vitti are partnering to pursue a number of Investigational New Drug (IND) studies in order to administer stem cells for the treatment of various conditions such as Duchenne Muscular Dystrophy, Autism, and Idiopathic Pediatric Autoimmune Disorders.

Please check back with us for updates and information regarding these studies.

Call our office for the latest information: 949-428-4500

Learn More About Stem Cells

Everything on our website comes from from reputable publications, books and scientific journals, most of which are available on PubMed and other government websites. These include Meta-Analysis’, Randomized Controlled Trials, Clinical Trials, Systematic Reviews, Books and Documents. We encourage you to read the science, in order to separate fact from fiction, so that you can arrive at a full understanding of what is best for your body. We would be honored to be a part of that educational journey with you.

  1. Li J, Luo M, Li B, Lou Y, Zhu Y, Bai X, Sun B, Lu X, Luo P. Immunomodulatory Activity of Mesenchymal Stem Cells in Lupus Nephritis: Advances and Applications. Front Immunol. 2022 Mar 10;13:843192. doi: 10.3389/fimmu.2022.843192. PMID: 35359961; PMCID: PMC8960601.
  2. Yamagishi H, Shigematsu K. Perspectives on Stem Cell-Based Regenerative Medicine with a Particular Emphasis on Mesenchymal Stem Cell Therapy. JMA J. 2022 Jan 17;5(1):36-43. doi: 10.31662/jmaj.2021-0080. Epub 2021 Dec 24. PMID: 35224258; PMCID: PMC8829109.
  3. Loke XY, Imran SAM, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and Regenerative Capacity of MSCs for Long-COVID. Int J Mol Sci. 2021 Nov 17;22(22):12421. doi: 10.3390/ijms222212421. PMID: 34830303; PMCID: PMC8625432.
  4. Xiang XN, Zhu SY, He HC, Yu X, Xu Y, He CQ. Mesenchymal stromal cell-based therapy for cartilage regeneration in knee osteoarthritis. Stem Cell Res Ther. 2022 Jan 10;13(1):14. doi: 10.1186/s13287-021-02689-9. PMID: 35012666; PMCID: PMC8751117.

Request a Consultation





    Do you want to receive emails from us about the treatment you selected? *

    Orange County

    Los Angeles

    Donate Now
    The AIMS Foundation provides Optimal Life for Humanity by treating a variety of debilitating conditions at no cost to the patient.
    Visit AMA’s Regenerative Medicine Division
    www.AmaRegenMed.com

    AIMS Patients Stories

    Watch Stories

    AMA Regenerative Medicine & Skincare | 1570 Brookhollow Dr., Santa Ana, CA 92705 | 6310 San Vicente Blvd STE 285, Los Angeles, CA, 90048 Disclaimer: though everything on our website comes directly from reputable publications and scientific journals; and though thousands of these articles are available on official government websites (https://pubmed.ncbi.nlm.nih.gov), they have not been evaluated by the Food and Drug Administration and the FDA has not certified, endorsed or approved any of the scientific findings as methods of treating or diagnosing any diseases or illnesses.